about the project
Medical news
For authors
Licensed books on medicine
<< Previous Next >>


In most cases, treatment is continued for 6 months or more (the dose of prednisone is gradually reduced).

The appointment of immunosuppressive therapy is indicated in the case of giant cell myocarditis confirmed by endomyocardial biopsy.

The possibilities of using immunomodulators are currently being studied; in 2002, the European randomized trial BICC (Betaferon in Chronic Viral Cardiomyopathy Trial) was launched.

The efficacy of immunoglobulin for intravenous administration in adults with myocarditis was evaluated in a multicenter study, Intervention in Myocarditis and Acute Cardiomyopathy (IMAC), in which 62 patients were randomized to infuse immunoglobulin at a dose of 2 g / kg body weight or placebo. No advantages of intravenous immunoglobulin administration were revealed, since after 6 months the increase in PV was 14% in both groups and after 12 months - 16% in the treatment group compared to 15% in the placebo group. Overall survival (events defined as death, heart transplantation or the need to use assistive devices to maintain LV function) was 91% after 1 year and 88% after 2 years; no significant differences between the groups were found.

In the complex therapy of myocarditis, the use of systemic enzyme therapy drugs is possible.

The treatment and outcome of myocarditis are significantly different depending on LV function.

With a mild course of myocarditis (suspected myocarditis) and the absence of LV dysfunction, drug therapy is not required; it is recommended to avoid aerobic exercise or lifting weights for at least 6-8 weeks. The examination, including ECG and echoCG, should be repeated 6-8 weeks after the onset of the disease to assess the progression of myocardial involvement.

With LV dysfunction in patients with heart failure, therapy is carried out according to general rules. The use of ACE inhibitors (with intolerance to angiotensin II receptor antagonists and p-adrenergic blockers) is recommended for all patients. Stagnation of the lungs or symptoms of fluid overload should be eliminated with the use of loop diuretics in the minimum effective dose. Digoxin is added to the treatment regimen in patients with NYHA FC III, however, its potential proarrhythmogenic and pro-inflammatory effects should be taken into account, prescribing it in minimum effective maintenance doses or not at all in patients with minimally expressed symptoms (FC I or II). Even with the use of cardiac glycosides in usual doses, there is a high risk of glycoside intoxication. HF with myocarditis is resistant to cardiac glycosides and diuretics. It is important to eliminate hypokalemia and acidosis. The use of peripheral vasodilators is justified for the treatment of refractory heart failure. Nitrates reduce the venous return of blood to the heart, the pressure in the vessels of the pulmonary circulation, that is, LV preload, which is manifested by clinical improvement. The use of cardiac glycosides against the background of peripheral vasodilators allows to achieve adequate digitalization in the absence of toxic effect.

In patients with fulminant myocarditis, mechanical devices can be used to support ventricular function, in cases where their condition does not improve, despite the maximum inotropic therapy.

In patients whose LV size and systolic function are fully normalized, therapy with ACE inhibitors and p-adrenoreceptor blockers can, in principle, be discontinued provided that LV function and chronic diseases are closely monitored. In many patients who have recovered, subjective limitations in functional ability and objective limitations in exercise tests may be present, possibly due to a slower restoration of LV diastolic function.

Indirect anticoagulants are prescribed for patients with thromboembolic complications (including a history), the presence of blood clots in the cavities of the heart, and atrial fibrillation in patients with cardiomegaly.

In case of rhythm disturbances, antiarrhythmic drugs are prescribed or a cardioverter-defibrillator, pacemaker are implanted.

Heart transplantation should be planned only in the later stages of the disease, especially given the high early postoperative mortality due to graft rejection in patients whose immune system is initially activated against myocyte antigens. In case of transplant rejection, which often develops in the first 3 months after heart transplantation, GCS is prescribed in high doses (pulse therapy).

In the terminal stage, two-chamber stimulation is used, hardware maintenance of ventricular contraction.
<< Previous Next >>
= Skip to textbook content =


  1. Treatment of breast ulcers and treatment of consumption
    As for the ulcer, if it is in the respiratory tube, the medicine quickly [reaches] it. The patient should lie on his back, hold the medicine in his mouth and swallow the saliva little by little, without sending it to the throat a lot at once, as this will cause a cough. One needs to relax the throat muscles so that the [medicine] goes down into it without causing a cough. Glues and dryers serve as medicines
  2. LECTURE No. 17. Bronchial obstructive syndrome. Clinic, diagnosis, treatment. Respiratory failure. Clinic, diagnosis, treatment
    Bronchial obstructive syndrome is a clinical symptom complex observed in patients with generalized impaired patency of the bronchial pathways, its leading manifestation is expiratory dyspnea, asthma attacks. Diseases accompanied by airway obstruction. The main causes of airway obstruction in children. 1. Obstruction of the upper respiratory tract: 1) acquired: a)
    Pneumoconiosis - due to the development of fibrotic changes in the lungs as a result of prolonged inhalation of the industry. dust. According to the etiology, 6 groups of PCs are distinguished: 1) silicosis-PC from inhalation of silica dust (silicon oxide) 2) silicotosis-PC from inhalation of silica dust, soda-silicon dioxide in a bound state with other elements # astestosis, talcosis. 3) metallokoniosis - PC from dust Me: Al - aluminum, iron oxides - siderosis. 4)
  4. LECTURE No. 19. Respiratory diseases. Acute bronchitis. Clinic, diagnosis, treatment, prevention. Chronical bronchitis. Clinic, diagnosis, treatment, prevention
    LECTURE No. 19. Respiratory diseases. Acute bronchitis. Clinic, diagnosis, treatment, prevention. Chronical bronchitis. Clinic, diagnosis, treatment,
    One of the basic principles of treatment is the prevention of possible MI. All patients with unstable angina pectoris / pre-infarction condition / are subject to mandatory hospitalization with the appointment of strict bed rest, painkillers, antianginal drugs, thrombolytics and anticoagulants as early as possible. In the case of acute myocardial infarction, the most critical period in his
  6. Treatment
    - timely treatment ensures the recovery of sick animals. With this infection, they get a good effect after treating patients with immune globulins and antibiotics. Such treatment can be defined as specific. Immune globulins neutralize Salmonella with specific antibodies. But with salmonellosis, like other factor infections, it is very often provoked
  7. Treatment
    In the absence of timely adequate treatment, patients with renovascular hypertension develop severe cardiovascular complications and / or chronic renal failure. This determines the importance of timely diagnosis and, when confirming the diagnosis of "renovascular hypertension," referral to specialized centers to determine treatment tactics. Currently, there are three approaches to the treatment of patients with renovascular hypertension:
  8. Treatment
    With the development of obstetric and gynecological science, endocrinology, biochemistry, approaches to the treatment of endometriosis have also improved. It is possible to note several stages in the evolution of drug treatment of this disease. One of them is the treatment of endometriosis with pseudopregnancy. Today it is already known that in the endometrioid tissue there is a lower concentration of hormone receptors in comparison with
  9. Treatment.
    As you know, representatives of the ubiquitous conditionally pathogenic microflora that are involved in the formation of the pathological process of the mammary gland are very sensitive to antibiotics and sulfonamides. Therefore, the use of these drugs for the treatment of mastitis gives a good therapeutic effect. Some researchers even recommended treating all cows with them to prevent pathology of the udder.
  10. Treatment
    Comprehensive treatment of IE should be etiotropic, pathogenetic and symptomatic. Treatment includes: the appointment of 2 or 3 AB synergistic action, taking into account the sensitivity of the selected microorganism, the use of hyperimmune plasma and glucocorticoids, correction of heart failure, symptomatic treatment and extracorporeal hemocorrection, which reduces the resistance of pathogenic bacteria to AB.
Medical portal "MedguideBook" © 2014-2019